ReviewCurrent opinion in biotechnology2025
Harnessing the potential of microbial methane utilization for chasing sustainability.
Review in Current opinion in biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Membrane properties modulate methane oxidation by particulate methane monooxygenase.The Journal of biological chemistry · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Microbial methane utilization (known as methanotrophy) serves as a gatekeeper of methane emissions in numerous ecosystems. Methanotrophy became a platform for the production of biofuels, value-added chemicals, and novel molecules from natural or renewable gas. Methanotroph- driven Methanotroph-driven processes enable novel solutions for bioremediation, biomining of minerals, methane mitigation, and agriculture. All applications rely on in-depth understanding of methanotroph biochemistry, genetics, physiology, and ecological fitness. Here, we review recent advances in the enzymology of methane utilization and methanotroph carbon assimilation pathways as well as progress toward engineering both native and synthetic methanotrophs. New bioreactor approaches to overcoming methane and oxygen mass transfer limitations are also described. Continued research in these areas is critical to future success in methanotroph optimization for industrial processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.